Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34⁺ cells using the auto-erasable Sendai virus vector.

ABSTRACT:

Background

Disease modeling with patient-derived induced pluripotent stem cells (iPSCs) is a powerful tool for elucidating the mechanisms underlying disease pathogenesis and developing safe and effective treatments. Patient peripheral blood (PB) cells are used for iPSC generation in many cases since they can be collected with minimum invasiveness. To derive iPSCs that lack immunoreceptor gene rearrangements, hematopoietic stem and progenitor cells (HSPCs) are often targeted as the reprogramming source. However, the current protocols generally require HSPC mobilization and/or ex vivo expansion owing to their sparsity at the steady state and low reprogramming efficiencies, making the overall procedure costly, laborious, and time-consuming.

Methods

We have established a highly

SUBMITTER: Okumura T 

PROVIDER: S-EPMC6591940 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature